Department of Cardiovascular Medicine, University of Texas Medical Branch, Galveston, TX, USA.
Weill Cornell Medicine-Qatar, Doha, Qatar.
Vasc Med. 2021 Apr;26(2):155-163. doi: 10.1177/1358863X20951270. Epub 2020 Oct 1.
There is a paucity of data on the outcomes and revascularization strategies for critical limb ischemia (CLI) among patients with chronic kidney disease (CKD). Hence, we conducted a nationwide analysis to evaluate the trends and outcomes of hospitalizations for CLI with CKD. The National Inpatient Sample database (2002-2015) was queried for hospitalizations for CLI. The trends of hospitalizations for CLI with CKD were reported, and endovascular versus surgical revascularization strategies for CLI with CKD were compared. The main study outcome was in-hospital mortality. The analysis included 2,139,640 hospitalizations for CLI, of which 484,224 (22.6%) had CKD. There was an increase in hospitalizations for CLI with CKD (P = 0.01), but a reduction in hospitalizations for CLI without CKD (P = 0.01). Patients with CLI and CKD were less likely to undergo revascularization compared with patients without CKD. CLI with CKD had higher rates of in-hospital mortality (4.8% vs 2.5%, adjusted odds ratio (OR) 2.01; 95% CI 1.93-2.11) and major amputation compared with no CKD. Revascularization for CLI with CKD was associated with lower rates of mortality (3.7% vs 5.3%, adjusted-OR 0.78; 95% CI 0.72-0.84) and major amputation compared with no revascularization. Compared with endovascular revascularization, surgical revascularization for CLI with CKD was associated with higher rates of in-hospital mortality (4.7% vs 2.7%, adjusted-OR 1.67; 95% CI 1.43-1.94). In conclusion, this contemporary observational analysis showed an increase in hospitalizations for CLI among patients with CKD. CLI with CKD was associated with higher in-hospital mortality compared with no CKD. Compared with endovascular therapy, surgical revascularization for CLI with CKD was associated with higher in-hospital mortality.
慢性肾脏病患者的肢体严重缺血(CLI)结局和血运重建策略的数据很少。因此,我们进行了一项全国性分析,以评估慢性肾脏病患者 CLI 的住院趋势和结局。使用国家住院患者样本数据库(2002-2015 年)查询 CLI 住院患者。报告了慢性肾脏病患者 CLI 住院的趋势,并比较了慢性肾脏病患者 CLI 的血管内与手术血运重建策略。主要研究结局为住院期间死亡率。分析共纳入 2139640 例 CLI 住院患者,其中 484224 例(22.6%)患有慢性肾脏病。患有慢性肾脏病的 CLI 住院患者数量增加(P=0.01),但无慢性肾脏病的 CLI 住院患者数量减少(P=0.01)。与无慢性肾脏病的患者相比,患有慢性肾脏病的 CLI 患者接受血运重建的可能性较小。患有慢性肾脏病的 CLI 患者的住院期间死亡率(4.8%比 2.5%,调整后比值比(OR)2.01;95%CI 1.93-2.11)和主要截肢率(4.8%比 2.5%,调整后 OR 2.01;95%CI 1.93-2.11)均较高。与无血运重建相比,慢性肾脏病患者的 CLI 血运重建与死亡率(3.7%比 5.3%,调整后 OR 0.78;95%CI 0.72-0.84)和主要截肢率(3.7%比 5.3%,调整后 OR 0.78;95%CI 0.72-0.84)降低相关。与血管内血运重建相比,慢性肾脏病患者的 CLI 手术血运重建与更高的住院期间死亡率(4.7%比 2.7%,调整后 OR 1.67;95%CI 1.43-1.94)相关。总之,这项现代观察性分析显示,慢性肾脏病患者的 CLI 住院人数有所增加。与无慢性肾脏病的患者相比,患有慢性肾脏病的 CLI 患者的住院期间死亡率更高。与血管内治疗相比,慢性肾脏病患者的 CLI 手术血运重建与更高的住院期间死亡率相关。